DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Hamann PR. * Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R, Hallett W, Tsou H.-R, Upeslacis J, Shochat D, Mountain A, Flowers DA, Bernstein I. Celltech Chiroscience, Berkshire, UK; Wyeth-Ayerst Research, Pearl River and Fred Hutchinson Cancer Research Center, Seattle, USA
Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody-Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia.
Bioconjugate Chem. 2002;
13: 47-58
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.